Tjalf Ziemssen

17.7k total citations · 1 hit paper
466 papers, 10.9k citations indexed

About

Tjalf Ziemssen is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Tjalf Ziemssen has authored 466 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 254 papers in Pathology and Forensic Medicine, 86 papers in Neurology and 69 papers in Molecular Biology. Recurrent topics in Tjalf Ziemssen's work include Multiple Sclerosis Research Studies (250 papers), Peripheral Neuropathies and Disorders (44 papers) and Immunotherapy and Immune Responses (41 papers). Tjalf Ziemssen is often cited by papers focused on Multiple Sclerosis Research Studies (250 papers), Peripheral Neuropathies and Disorders (44 papers) and Immunotherapy and Immune Responses (41 papers). Tjalf Ziemssen collaborates with scholars based in Germany, United States and Switzerland. Tjalf Ziemssen's co-authors include Katja Akgün, Rocco Haase, Heinz Reichmann, Katja Thomas, Undine Proschmann, Simone Kern, Christian Beste, Wiebke Schrempf, Hernán Inojosa and Moritz Mückschel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Tjalf Ziemssen

436 papers receiving 10.7k citations

Hit Papers

Identifying prodromal Parkinson's disease: Pre‐Motor diso... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
    2012 433 citations Tjalf Ziemssen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tjalf Ziemssen Germany 52 4.8k 2.6k 1.7k 1.6k 1.3k 466 10.9k
Brian C. Healy United States 51 4.8k 1.0× 1.8k 0.7× 1.2k 0.7× 1.7k 1.1× 612 0.5× 291 9.9k
Sven G. Meuth Germany 59 3.1k 0.6× 2.2k 0.8× 2.7k 1.6× 4.1k 2.6× 2.6k 2.0× 561 14.0k
Jacques De Keyser Netherlands 61 3.1k 0.7× 3.1k 1.2× 978 0.6× 2.3k 1.5× 2.0k 1.6× 329 12.8k
Vittorio Martinelli Italy 57 7.8k 1.6× 3.5k 1.3× 908 0.5× 1.8k 1.1× 999 0.8× 282 10.9k
Gianluigi Mancardi Italy 60 5.2k 1.1× 3.2k 1.2× 2.4k 1.4× 2.6k 1.6× 1.5k 1.2× 320 14.3k
Douglas S. Goodin United States 56 5.3k 1.1× 2.7k 1.0× 1.1k 0.6× 1.1k 0.7× 662 0.5× 150 10.3k
Carlo Pozzilli Italy 69 10.0k 2.1× 4.1k 1.5× 1.6k 1.0× 1.5k 1.0× 1.3k 1.0× 385 14.8k
Marco Rovaris Italy 61 8.9k 1.9× 3.6k 1.4× 855 0.5× 1.6k 1.0× 944 0.7× 308 12.1k
María Trojano Italy 57 8.0k 1.7× 2.9k 1.1× 1.3k 0.8× 1.6k 1.0× 970 0.8× 304 11.3k
Patrick Vermersch France 54 6.8k 1.4× 4.6k 1.7× 992 0.6× 1.9k 1.2× 1.5k 1.1× 391 13.7k

Countries citing papers authored by Tjalf Ziemssen

Since Specialization
Citations

This map shows the geographic impact of Tjalf Ziemssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tjalf Ziemssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tjalf Ziemssen more than expected).

Fields of papers citing papers by Tjalf Ziemssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tjalf Ziemssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tjalf Ziemssen. The network helps show where Tjalf Ziemssen may publish in the future.

Co-authorship network of co-authors of Tjalf Ziemssen

This figure shows the co-authorship network connecting the top 25 collaborators of Tjalf Ziemssen. A scholar is included among the top collaborators of Tjalf Ziemssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tjalf Ziemssen. Tjalf Ziemssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mückschel, Moritz, et al.. (2025). Variations in neuronal cytoskeletal integrity affect directed communication in distributed networks during inhibitory control. Communications Biology. 8(1). 516–516. 1 indexed citations
2.
Ziemssen, Tjalf, Ann Bass, Bart Van Wijmeersch, et al.. (2025). Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study. Therapeutic Advances in Neurological Disorders. 18. 4233587663–4233587663. 2 indexed citations
3.
4.
Inojosa, Hernán, et al.. (2025). Education Research: Can Large Language Models Match MS Specialist Training?. PubMed. 4(4). e200260–e200260.
5.
Hartmann, Maximilian, et al.. (2024). The Association of Age, Sex, and BMI on Lower Limb Neuromuscular and Muscle Mechanical Function in People with Multiple Sclerosis. Biomedicines. 12(5). 971–971. 2 indexed citations
6.
Scholz, Maria, et al.. (2024). Using machine learning algorithms to detect fear of falling in people with multiple sclerosis in standardized gait analysis. Multiple Sclerosis and Related Disorders. 88. 105721–105721. 3 indexed citations
7.
8.
9.
Moser, Tobias, Tjalf Ziemssen, & Johann Sellner. (2022). Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety. Wiener Medizinische Wochenschrift. 172(15-16). 365–372. 14 indexed citations
10.
Inojosa, Hernán, Undine Proschmann, Katja Akgün, & Tjalf Ziemssen. (2022). The need for a strategic therapeutic approach: multiple sclerosis in check. Therapeutic Advances in Chronic Disease. 13. 364111608–364111608. 27 indexed citations
11.
Haase, Rocco, et al.. (2021). Automated Analysis of the Two-Minute Walk Test in Clinical Practice Using Accelerometer Data. Brain Sciences. 11(11). 1507–1507. 4 indexed citations
12.
13.
King, Joseph A., Friederike I. Tam, Maria Seidel, et al.. (2021). Differential longitudinal changes of neuronal and glial damage markers in anorexia nervosa after partial weight restoration. Translational Psychiatry. 11(1). 86–86. 26 indexed citations
14.
Schriefer, Dirk, et al.. (2020). Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Haase, Rocco, Raimar Kern, Dirk Schriefer, et al.. (2020). The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study. Journal of Medical Internet Research. 22(3). e17921–e17921. 18 indexed citations
16.
17.
Ziemssen, Tjalf, et al.. (2019). Remote-Sensoring – neue Optionen des Progressionsmonitorings bei Multipler Sklerose. Der Nervenarzt. 90(12). 1239–1244. 8 indexed citations
18.
Reimann, Manja, et al.. (2015). Insulin is a key determinant of elevated retinal arteriolar flicker response in insulin-resistant individuals. Diabetologia. 58(9). 2154–2160. 3 indexed citations
19.
Kern, Simone, et al.. (2009). Effect of BEMER Magnetic Field Therapy on the Level of Fatigue in Patients with Multiple Sclerosis: A Randomized, Double-Blind Controlled Trial. The Journal of Alternative and Complementary Medicine. 15(5). 507–511. 31 indexed citations
20.
Schrempf, Wiebke & Tjalf Ziemssen. (2007). Glatiramer acetate: Mechanisms of action in multiple sclerosis. Autoimmunity Reviews. 6(7). 469–475. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian C. Healy Breakdown of academic impact, for papers by Sven G. Meuth Breakdown of academic impact, for papers by Jacques De Keyser Breakdown of academic impact, for papers by Vittorio Martinelli Breakdown of academic impact, for papers by Gianluigi Mancardi Breakdown of academic impact, for papers by Douglas S. Goodin Breakdown of academic impact, for papers by Carlo Pozzilli Breakdown of academic impact, for papers by Marco Rovaris Breakdown of academic impact, for papers by María Trojano Breakdown of academic impact, for papers by Patrick Vermersch
Rankless by CCL
2026